Literature DB >> 25202922

HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.

Marta E Bull1, Jillian Legard, Kenneth Tapia, Bess Sorensen, Susan E Cohn, Rochelle Garcia, Sarah E Holte, Robert W Coombs, Jane E Hitti.   

Abstract

BACKGROUND: HIV-1 shedding from the female genital tract is associated with increased sexual and perinatal transmission and has been broadly evaluated in cross-sectional studies. However, few longitudinal studies have evaluated how the immune microenvironment effects shedding.
METHODS: Thirty-nine HIV-1-infected women had blood, cervicovaginal lavage, and biopsies of the uterine cervix taken quarterly for up to 5 years. Cytokines/chemokines were quantified by Luminex assay in cervicovaginal lavage, and cellular phenotypes were characterized using immunohistochemistry in cervical biopsies. Comparisons of cytokine/chemokine concentrations and the percent of tissue staining positive for T cells were compared using generalized estimating equations between non-shedding and shedding visits across all women and within a subgroup of women who intermittently shed HIV-1.
RESULTS: Genital HIV-1 shedding was more common when plasma HIV-1 was detected. Cytokines associated with cell growth (interleukin-7), Th1 cells/inflammation (interleukin-12p70), and fractalkine were significantly increased at shedding visits compared with non-shedding visits within intermittent shedders and across all subjects. Within intermittent shedders and across all subjects, FOXP3 T cells were significantly decreased at shedding visits. However, there were significant increases in CD8 cells and proportions of CD8FOXP3 T cells associated with HIV-1 shedding.
CONCLUSIONS: Within intermittent HIV-1 shedders, decreases in FOXP3 T cells at the shedding visit suggests that local HIV-1 replication leads to CD4 T-cell depletion, with increases in the proportion of CD8FOXP3 cells. HIV-1-infected cell loss may promote a cytokine milieu that maintains cellular homeostasis and increases immune suppressor cells in response to HIV-1 replication in the cervical tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25202922      PMCID: PMC4213308          DOI: 10.1097/QAI.0000000000000336

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  48 in total

1.  Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.

Authors:  Caroline Mitchell; Jane Hitti; Kathleen Paul; Kathy Agnew; Susan E Cohn; Amneris E Luque; Robert Coombs
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

2.  Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.

Authors:  S D Lawn; S Subbarao; T C Wright; T Evans-Strickfaden; T V Ellerbrock; J L Lennox; S T Butera; C E Hart
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

3.  Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.

Authors:  Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine S Odem-Davis; Barbra A Richardsonb; Julie Overbaugh
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

4.  CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.

Authors:  Masakatsu Suzuki; Ann L Jagger; Christine Konya; Yasuhiro Shimojima; Sergey Pryshchep; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Immunol       Date:  2012-07-20       Impact factor: 5.422

5.  Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility.

Authors:  Lyle R McKinnon; Billy Nyanga; Duncan Chege; Preston Izulla; Makobu Kimani; Sanja Huibner; Lawrence Gelmon; Katharine E Block; Claudia Cicala; A Omu Anzala; James Arthos; Joshua Kimani; Rupert Kaul
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

6.  Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens.

Authors:  P A Crowley-Nowick; J H Ellenberg; S H Vermund; S D Douglas; C A Holland; A B Moscicki
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

7.  Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.

Authors:  James Homans; Shawna Christensen; Tracey Stiller; Chia-Hao Wang; Wendy Mack; Kathryn Anastos; Howard Minkoff; Mary Young; Ruth Greenblatt; Mardge Cohen; Howard Strickler; Roksana Karim; Lashonda Yvette Spencer; Eva Operskalski; Toinette Frederick; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2012-05-01       Impact factor: 3.731

8.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

9.  Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study.

Authors:  Y Lévy; I Sereti; G Tambussi; J P Routy; J D Lelièvre; J F Delfraissy; J M Molina; M Fischl; C Goujard; B Rodriguez; C Rouzioux; V Avettand-Fenoël; T Croughs; S Beq; M Morre; J F Poulin; R P Sekaly; R Thiebaut; M M Lederman
Journal:  Clin Infect Dis       Date:  2012-05-01       Impact factor: 9.079

10.  Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.

Authors:  Craig R Cohen; Jairam R Lingappa; Jared M Baeten; Musa O Ngayo; Carol A Spiegel; Ting Hong; Deborah Donnell; Connie Celum; Saidi Kapiga; Sinead Delany; Elizabeth A Bukusi
Journal:  PLoS Med       Date:  2012-06-26       Impact factor: 11.069

View more
  5 in total

1.  Systemic Immune Activation and HIV Shedding in the Female Genital Tract.

Authors:  LaShonda Y Spencer; Shawna Christiansen; Chia-Hao H Wang; Wendy J Mack; Mary Young; Howard D Strickler; Kathryn Anastos; Howard Minkoff; Mardge Cohen; Ruth M Geenblatt; Roksana Karim; Eva Operskalski; Toni Frederick; James D Homans; Alan Landay; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

2.  Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.

Authors:  Julie A E Nelson; Kristina De Paris; Catalina Ramirez; Andrew Edmonds; Katie R Mollan; Camden P Bay; Kara Compliment; Betsy C Herold; Kathryn Anastos; Howard Minkoff; Seble Kassaye; Dominika L Seidman; Audrey L French; Elizabeth T Golub; Anandi N Sheth; Christina Ochsenbauer; Ronald Swanstrom; Joseph J Eron; Adaora A Adimora
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

3.  Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women.

Authors:  Smita S Iyer; Michael J Sabula; C Christina Mehta; Lisa B Haddad; Nakita L Brown; Rama R Amara; Igho Ofotokun; Anandi N Sheth
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

4.  A pro-inflammatory CD8+ T-cell subset patrols the cervicovaginal tract.

Authors:  Laura Pattacini; Amanda Woodward Davis; Julie Czartoski; Florian Mair; Scott Presnell; Sean M Hughes; Ollivier Hyrien; Gretchen M Lentz; Anna C Kirby; Michael F Fialkow; Florian Hladik; Martin Prlic; Jennifer M Lund
Journal:  Mucosal Immunol       Date:  2019-07-16       Impact factor: 8.701

Review 5.  The Vaginal Virome-Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes?

Authors:  Anna-Ursula Happel; Arvind Varsani; Christina Balle; Jo-Ann Passmore; Heather Jaspan
Journal:  Viruses       Date:  2020-07-30       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.